기업

길리어드

주관 임상 66건 · 진행 중 186건 · FDA 승인 0

주관 임상 단계 분포

3상212상201상122/3상71/2상3단계 미표기24상1

관련 뉴스

전체 뉴스 →
  • 정책이벤트2026-07-16

    길리어드, HIV 치료제 데스코비 광고 캠페인으로 칸 라이언즈 동상 수상

    길리어드 사이언스 캐나다와 광고대행사 더 로컬 콜렉티브가 HIV 예방약 데스코비(Descovy)를 위해 제작한 캠페인이 칸 라이언즈 국제광고제에서 동상을 수상했다. 해당 캠페인은 AI로 생성한 동물 이미지를 활용한 것이 특징이다. 이번 수상은 제약업계 마케팅 부문에서 이루어졌다.

    Fierce Pharma ↗

진행 중인 임상

  • 2상모집 예정협력· Advanced or Metastatic Solid Tumour

    SCALp Cooling for pReventing aLopecia With nEw anTibody-drug Conjugates

    NCT07474558
  • 3상모집 예정협력· HIV Infection

    Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy

    NCT07658976
  • 4상모집 예정협력· HIV - Human Immunodeficiency Virus

    Combating Related Epidemics in HCV

    NCT07560046
  • 1상모집 예정· Solid Tumor

    A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid Tumors

    NCT07703878
  • 해당없음모집 예정협력· HIV Prevention

    Leveraging Chatbot to Improve PrEP in the Southern United States

    NCT05968755
  • 해당없음모집 중협력· Shared Decision-Making

    Empowering Monterey Bay Residents for Activated, Collaborative, and Equitable Care

    NCT07652359
  • 3상모집 예정· HIV-1-infection

    Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens

    NCT07683000
  • 2/3상모집 예정· HIV-1-infection

    Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment

    NCT07708727
  • 3상모집 예정· HIV Infections

    Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

    NCT07682961
  • 3상모집 예정협력· Talaromycosis

    Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST)

    NCT06525389
  • 2상모집 중· HER2-negative

    Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas

    NCT07546812
  • 3상모집 예정협력· Breast Cancer

    NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast Cancer

    NCT07178730
  • 4상모집 중협력· HIV -1 Infection

    REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE

    NCT07476339
  • 2상모집 중· HIV-1-infection

    A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1

    NCT07645287
  • 1상모집 중· Advanced Solid Tumors

    Study of GS-2426 in Participants With Advanced Solid Tumors

    NCT07601243
  • 해당없음모집 예정협력· HIV

    HIV/HBV/HCV Triple Screening in Primary Care

    NCT07031219
  • 2상모집 중협력· Small Cell Lung Cancer ( SCLC )

    Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

    NCT07339059
  • 해당없음모집 중협력· Breast Cancer Metastatic

    Decision Support Tool for Patients With Advanced Breast Cancer

    NCT07635147
  • 3상모집 중협력· Relapsed or Refractory Large B-cell Lymphoma

    Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy

    NCT07479797
  • 2상모집 중· Advanced Microsatellite Stable Colorectal Cancer

    Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer

    NCT07527858

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.